Scorpion venom offers new hope for breast cancer patients: Study
Brazilian scientists have discovered a molecule, BamazScplp1, in Amazonian scorpion venom that shows potential in treating breast cancer. Early tests indicate the molecule effectively kills cancer cells through necrosis, similar to the chemotherapy drug paclitaxel. Researchers are using yeast to mass-produce the molecule, paving the way for less invasive breast cancer therapies.
Brazilian scientists have discovered a molecule, BamazScplp1, in Amazonian scorpion venom that shows potential in treating breast cancer. Early tests indicate the molecule effectively kills cancer cells through necrosis, similar to the chemotherapy drug paclitaxel. Researchers are using yeast to mass-produce the molecule, paving the way for less invasive breast cancer therapies.
